688271 联影医疗
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入10,580,22719.43%13,800,25210,300,10411,410,7669,238,123
减:营业总成本9,800,40923.76%12,083,5349,385,2729,857,9467,774,181
    其中:营业成本5,691,68221.26%7,312,5825,300,1626,039,1594,769,998
               财务费用115,957-364.60%(30,626)(112,290)(148,887)(98,725)
               资产减值损失144-70.02%1,30313,843(42,886)(74,747)
公允价值变动收益(6,687)-84.01%(37,114)37,000(6,063)28,500
投资收益48,310-20.39%80,51398,074110,34512,667
    其中:对联营企业和合营企业的投资收益(7,215)-496.58%2,100(5,623)(15,872)(7,651)
营业利润1,143,222-3.21%2,000,3091,366,3562,141,5151,928,243
利润总额1,115,671-5.34%1,981,3951,351,7082,142,2551,919,795
减:所得税费用98,76229.53%137,348109,784164,500269,710
净利润1,016,909-7.75%1,844,0471,241,9241,977,7551,650,086
减:非控股权益(18,196)1.49%(25,253)(19,945)3,462(5,998)
股东净利润1,035,105-7.60%1,869,3011,261,8691,974,2921,656,084

市场价值指针
每股收益 (元) *1.260-7.35%2.2801.5402.4002.190
每股派息 (元) *0.1300.00%0.3100.2000.2500.201
每股净资产 (元) *26.7926.12%26.17424.15022.89221.214
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容